Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of TW200744579ApublicationCriticalpatent/TW200744579A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention is a use of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as defined for the manufacture of a medicament for the glucose related disorders and lipid related disorders. The present invention is further directed to uses of an anti-diabetic agent, and anti-lipid agent and / or an anti-obesity agent.
TW095147359A2005-12-192006-12-18Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
TW200744579A
(en)
APPLICATION OF 4-CYCLOPROPILMETOXY-N- (3,5-DICHLOR-1-OXIDO-CLEAN-4-PYRIDIN-4-IL) -5- (METHOXI) -PYRIDIN-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS, CONNECTED CHAPTER-CHARACOXYLIDE